MTE #17: Unique Aspects of Managing Hepatitis C Virus Infection in Persons With Cancer

Nov 17 2024
Convention Center: Room 33 C
7:00 AM - 7:45 AM
Ticketed Event

World Class Speakers

Jonathan M Fenkel, MD, FAASLD, FACP
Discussion Leader

Jonathan M Fenkel, MD, FAASLD, FACP
Harrys A Torres, MD, FAASLD
Discussion Leader

Harrys A Torres, MD, FAASLD

The University of Texas MD Anderson Cancer Center

Description

Experts discuss unique considerations related to HCV infection among persons with cancer. Topics include the rationale for HCV screening in persons with cancer; monitoring HCV-infected persons with cancer not receiving direct-acting antiviral (DAA) treatment; and timing and benefits of DAA therapy in relation to cancer treatment.

 

 

Journey Maps

Presentations

12:16 AM - 12:16 AM
Nov 17 2024
San Diego, CA

HCV Infection Care Within Oncology Programs

Jonathan M Fenkel, MD, FAASLD, FACP, Discussion Leader
Harrys A Torres, MD, FAASLD, Discussion Leader
Hepatitis

Objectives

  • Review optimal HCV screening strategies in persons with cancer.
  • Describe and contrast HCV to HBV or HEV reactivation in persons with cancer.
  • Discuss the benefits and timing of DAA treatment in persons with cancer and chronic HCV infection.
  • Review the barriers to HCV infection treatment in persons with cancer.